The Net Margin of Bafna Pharmaceuticals Ltd (BAFNAPH.NS) is 4.82%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | 4.82% |
| 2023-03-31 | 9.82% |
| 2022-03-31 | 6.05% |
| 2021-03-31 | 8.19% |
| 2020-03-31 | -59.34% |
| 2019-03-31 | -43.25% |
| 2018-03-31 | -35.49% |
| 2017-03-31 | -29.39% |
| 2016-03-31 | -16.44% |
| 2015-03-31 | 6.33% |